Westwood Management Corporation’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,000
Closed -$101K 55
2023
Q2
$101K Sell
14,000
-12,000
-46% -$102K 0.01% 62
2023
Q1
$219K Hold
26,000
0.03% 68
2022
Q4
$220K Hold
26,000
0.03% 66
2022
Q3
$269K Hold
26,000
0.04% 61
2022
Q2
$339K Hold
26,000
0.04% 57
2022
Q1
$271K Hold
26,000
0.03% 70
2021
Q4
$292K Hold
26,000
0.02% 68
2021
Q3
$461K Hold
26,000
0.04% 57
2021
Q2
$496K Hold
26,000
0.04% 61
2021
Q1
$550K Hold
26,000
0.05% 56
2020
Q4
$413K Buy
+26,000
New +$233K 0.03% 56
2020
Q3
Sell
-17,500
Closed -$62K 67
2020
Q2
$62K Hold
17,500
0.01% 70
2020
Q1
$63K Hold
17,500
0.01% 65
2019
Q4
$84K Hold
17,500
0.01% 71
2019
Q3
$89K Buy
+17,500
New +$71.7K 0.01% 72

Other funds holding CLPT

Westwood Management Corporation's CLPT Position: Q3 2023 in Review

Westwood Management Corporation sold out of ClearPoint Neuro (CLPT) in Q3 2023, closing a stake of 14,000 shares — an estimated $101K sold.

Westwood Management Corporation first reported a position in CLPT in Q3 2019 and held it in 15 quarters. The position peaked at $550K in Q1 2021. 63 funds tracked by Wall St. Rank hold CLPT as of Q3 2023.

  • Westwood Management Corporation reported no remaining ClearPoint Neuro position as of Q3 2023 after selling out during the quarter.
  • Westwood Management Corporation sold 14,000 ClearPoint Neuro shares in Q3 2023, an estimated $101K.
  • Westwood Management Corporation first reported a position in ClearPoint Neuro in Q3 2019 and held it in 15 quarters.
  • Westwood Management Corporation's ClearPoint Neuro position peaked at $550K in Q1 2021.
  • 63 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2023.

Based on Westwood Management Corporation's 13F filing for Q3 2023, filed 27 Oct 2023.